Laser Atherectomy for the Treatment of Peripheral Arterial Disease

Annals of Vascular Surgery

Volumn 44, Issue , 2017, Pages 269-276

  Mallios, Alexandros ^a,b   Blebea, John ^a   Buster, Bryan ^a   Messiner, Ryan ^a   Taubman, Kevin ^a   MA, Harry ^a  

^a University of Oklahoma Tulsa College of Medicine   (United States)

^b INSTITUT MUTUALISTE MONTSOURIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ATHERECTOMY; CLAUDICATION; CONFERENCE PAPER; CRITICAL LIMB ISCHEMIA; DIABETES MELLITUS; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; UNIVARIATE ANALYSIS; ADULT; ADVERSE DEVICE EFFECT; AMPUTATION; CRITICAL ILLNESS; DEVICES; ELECTRONIC HEALTH RECORD; FRANCE; INTERMITTENT CLAUDICATION; ISCHEMIA; LASER; LIMB SALVAGE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; RISK FACTOR; STATISTICAL MODEL; STENT; TERTIARY CARE CENTER; TIME FACTOR; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; AMPUTATION; ANGIOPLASTY, BALLOON; ATHERECTOMY; CRITICAL ILLNESS; ELECTRONIC HEALTH RECORDS; FEMALE; HOSPITALS, UNIVERSITY; HUMANS; INTERMITTENT CLAUDICATION; ISCHEMIA; LASERS; LIMB SALVAGE; LOGISTIC MODELS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; ODDS RATIO; PARIS; PERIPHERAL ARTERIAL DISEASE; RETROSPECTIVE STUDIES; RISK FACTORS; STENTS; TERTIARY CARE CENTERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 85020637314     PISSN: 08905096     EISSN: 16155947     Source Type: Journal    
DOI: 10.1016/j.avsg.2017.04.013     Document Type: Conference Paper

References (30)

1. Hirsch, A.T., Criqui, M.H., Treat-Jacobson, D., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. JAMA 286 (2001), 1317–1324.
2. Kasapis, C., Gurm, H.S., Current approach to the diagnosis and treatment of femoral-popliteal arterial disease. A systematic review. Curr Cardiol Rev 5 (2009), 296–311.
3. Gallagher, K.A., Meltzer, A.J., Ravin, R.A., et al. Endovascular management as first therapy for chronic total occlusion of the lower extremity arteries: comparison of balloon angioplasty, stenting, and directional atherectomy. J Endovasc Ther 18 (2011), 624–637.
4. Zeller, T., Tiefenbacher, C., Steinkamp, H.J., et al. Nitinol stent implantation in TASC A and B superficial femoral artery lesions: the Femoral Artery Conformexx Trial (FACT). J Endovasc Ther 15 (2008), 390–398.
5. Davaine, J.M., Azema, L., Guyomarch, B., et al. One-year clinical outcome after primary stenting for Trans-Atlantic Inter-Society Consensus (TASC) C and D femoropopliteal lesions (the STELLA “STEnting Long de L'Artere femorale superficielle” cohort). Eur J Vasc Endovasc Surg 44 (2012), 432–441.
6. Lichtenberg, M., Stahlhoff, W., Boese, D., Superficial femoral artery TASC D Registry: twelve-month effectiveness analysis of the Pulsar-18 SE nitinol stent in patients with critical limb ischemia. J Cardiovasc Surg (Torino) 54 (2013), 433–439.
7. Schneider, J.R., Verta, M.J., Alonzo, M.J., et al. Results with Viabahn-assisted subintimal recanalization for TASC C and TASC D superficial femoral artery occlusive disease. Vasc Endovascular Surg 45 (2011), 391–397.
8. Sixt, S., Rastan, A., Beschorner, U., et al. Acute and long-term outcome of Silverhawk assisted atherectomy for femoro-popliteal lesions according the TASC II classification: a single-center experience. Vasa 39 (2010), 229–236.
9. Krankenberg, H., Schluter, M., Steinkamp, H.J., et al. Nitinol stent implantation versus percutaneous transluminal angioplasty in superficial femoral artery lesions up to 10 cm in length: the femoral artery stenting trial (FAST). Circulation 116 (2007), 285–292.
10. Schillinger, M., Sabeti, S., Loewe, C., et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 354 (2006), 1879–1888.
11. Lensvelt, M.M., Fritschy, W.M., van Oostayen, J.A., et al. Results of heparin-bonded ePTFE-covered stents for chronic occlusive superficial femoral artery disease. J Vasc Surg 56 (2012), 118–125.
12. Geraghty, P.J., Mewissen, M.W., Jaff, M.R., et al. Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease. J Vasc Surg 58 (2013), 386–395.e4.
13. Lammer, J., Bosiers, M., Zeller, T., et al. First clinical trial of nitinol selfexpanding everolimus-eluting stent implantation for peripheral arterial occlusive disease. J Vasc Surg 54 (2011), 394–401.
14. Samson, R.H., Showalter, D.P., Lepore, M. Jr., et al. CryoPlasty therapy of the superficial femoral and popliteal arteries: a reappraisal after 44 months' experience. J Vasc Surg 48 (2008), 634–637.
15. Minko, P., Katoh, M., Jaeger, S., et al. Atherectomy of heavily calcified femoropopliteal stenotic lesions. J Vasc Interv Radiol 22 (2011), 995–1000.
16. Trentmann, J., Charalambous, N., Djawanscher, M., et al. Safety and efficacy of directional atherectomy for the treatment of in-stent restenosis of the femoropopliteal artery. J Cardiovasc Surg (Torino) 51 (2010), 551–560.
17. McCarthy, W.J., Vogelzang, R.L., Nemcek, A.A. Jr., et al. Excimer laser-assisted femoral angioplasty: early results. J Vasc Surg 13 (1991), 607–614.
18. Blebea, J., Ouriel, K., Green, R.M., et al. Laser angioplasty in peripheral vascular disease: symptomatic versus hemodynamic results. J Vasc Surg 13 (1991), 222–228.
19. Todd, K.E. Jr., Ahanchi, S.S., Maurer, C.A., et al. Atherectomy offers no benefits over balloon angioplasty in tibial interventions for critical limb ischemia. J Vasc Surg 58 (2013), 941–948.
20. Wissgott, C., Kamusella, P., Ludtke, C., et al. Excimer laser atherectomy after unsuccessful angioplasty of TASC C and D lesions in femoropopliteal arteries. J Cardiovasc Surg (Torino) 54 (2013), 359–365.
21. Kim, J.H., Ahanchi, S.S., Panneton, J.M., Identifying the target lesions for 245 laser angioplasty cases and a review of the literature. Vasc Endovascular Surg 46 (2012), 640–647.
22. Dave, R.M., Patlola, R., Kollmeyer, K., et al. Excimer laser recanalization of femoropopliteal lesions and 1-year patency: results of the CELLO registry. J Endovasc Ther 16 (2009), 665–675.
23. Rastan, A., Sixt, S., Schwarzwälder, U., et al. Initial experience with directed laser atherectomy using the CLiRpath photoablation atherectomy system and bias sheath in superficial femoral artery lesions. J Endovasc Ther 14 (2007), 365–373.
24. Zhou, W., Bush, R.L., Lin, P.H., et al. Laser atherectomy for lower extremity revascularization: An adjunctive endovascular treatment option. Vasc Endovascular Surg 40 (2006), 268–274.
25. Stoner, M.C., deFreitas, D.J., Phade, S.V., et al. Mid-term results with laser atherectomy in the treatment of infrainguinal occlusive disease. J Vasc Surg 46 (2007), 289–295.
26. Kim, J., Ahanchi, S.S., Day, J., et al. Our Experience with Laser Angioplasty of 258 Lower Extremities: Statin Use Improves Patency. J Vasc Surg, 53, 2011, 60S.
27. Fernandez, N., McEnaney, R., Marone, L.K., et al. Predictors of failure and success of tibial interventions for critical limb ischemia. J Vasc Surg 52 (2010), 834–842.
28. Shrikhande, G.V., Khan, S.Z., Hussain, H.G., et al. Lesion types and device characteristics that predict distal embolization during percutaneous lower extremity interventions. J Vasc Surg 53 (2011), 347–352.
29. Sultan, S., Tawfick, W., Hynes, N., Cool excimer laser-assisted angioplasty (CELA) and tibial balloon angioplasty (TBA) in management of infragenicular arterial occlusion in critical lower limb ischemia (CLI). Vasc Endovascular Surg 47 (2013), 179–191.
30. Niccoli, G., Belloni, F., Cosentino, N., et al. Case-control registry of excimer laser coronary angioplasty versus distal protection devices in patients with acute coronary syndromes due to saphenous vein graft disease. Am J Cardiol 112 (2013), 1586–1591.